Literature DB >> 21238440

Comparison of two assays for serum 1,5-anhydroglucitol.

Elizabeth Selvin, Gregory P Rynders, Michael W Steffes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21238440      PMCID： PMC3043136          DOI： 10.1016/j.cca.2011.01.007

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  7 in total

1.  Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).

Authors:  Tomoko Suwa; Akio Ohta; Tomoya Matsui; Rieko Koganei; Hiroyuki Kato; Takehiro Kawata; Yukiyoshi Sada; Satoshi Ishii; Akihiko Kondo; Kaori Murakami; Takuyuki Katabami; Yasushi Tanaka
Journal:  Endocr J       Date:  2009-11-19       Impact factor: 2.349

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 3.  Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine.

Authors:  Mark W True
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.

Authors:  Jong Chul Won; Cheol-Young Park; Hyo-Soon Park; Ji Hoom Kim; Eun Sook Choi; Eun Jung Rhee; Won Young Lee; Ki Won Oh; Sun Woo Kim; Sung Woo Park
Journal:  Diabetes Res Clin Pract       Date:  2009-02-01       Impact factor: 5.602

5.  Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study.

Authors:  Lynne Wagenknecht; Bruce Wasserman; Lloyd Chambless; Josef Coresh; Aaron Folsom; Thomas Mosley; Christie Ballantyne; Richey Sharrett; Eric Boerwinkle
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-11       Impact factor: 7.792

6.  Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.

Authors:  Aparna Pal; Andrew J Farmer; Christina Dudley; Mary P Selwood; Beryl A Barrow; Rhiannon Klyne; Jilly P Grew; Mark I McCarthy; Anna L Gloyn; Katharine R Owen
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

7.  Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.

Authors:  Christoph Stettler; Matthias Stahl; Sabin Allemann; Peter Diem; Kurt Schmidlin; Marcel Zwahlen; Walter Riesen; Ulrich Keller; Emanuel Christ
Journal:  Diabetes Care       Date:  2008-04-21       Impact factor: 19.112
  7 in total
  17 in total

1.  Association of a Biomarker of Glucose Peaks, 1,5-Anhydroglucitol, With Subclinical Cardiovascular Disease.

Authors:  Menglu Liang; John William McEvoy; Yuan Chen; A Richey Sharrett; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-08-01       Impact factor: 19.112

2.  The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.

Authors:  Qiang Zhou; De-Bao Shi; Li-Ying Lv
Journal:  J Clin Lab Anal       Date:  2016-11-17       Impact factor: 2.352

3.  Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.

Authors:  Elizabeth Selvin; Bethany Warren; Xintong He; David B Sacks; Amy K Saenger
Journal:  Clin Chem       Date:  2018-02-07       Impact factor: 8.327

4.  Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.

Authors:  Stephen P Juraschek; Michael W Steffes; Elizabeth Selvin
Journal:  Clin Chem       Date:  2012-09-27       Impact factor: 8.327

5.  Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Authors:  S P Juraschek; E R Miller; L J Appel; R H Christenson; F M Sacks; E Selvin
Journal:  Diabet Med       Date:  2017-07-09       Impact factor: 4.359

6.  Glycemic excursions and subclinical cardiac damage in adults with type 2 diabetes: Results from the ADVANCE Trial.

Authors:  Mary R Rooney; Dan Wang; J William McEvoy; Stephen P Juraschek; John Chalmers; Mark Woodward; Elizabeth Selvin
Journal:  Diabetes Res Clin Pract       Date:  2021-11-17       Impact factor: 5.602

7.  Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ning Ding; Lucia Kwak; Shoshana H Ballew; Bernard Jaar; Ron C Hoogeveen; Christie M Ballantyne; A Richey Sharrett; Aaron R Folsom; Gerardo Heiss; Maya Salameh; Josef Coresh; Alan T Hirsch; Elizabeth Selvin; Kunihiro Matsushita
Journal:  Atherosclerosis       Date:  2018-04-30       Impact factor: 5.162

8.  Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.

Authors:  Elizabeth Selvin; Andreea M Rawlings; Morgan Grams; Ronald Klein; Michael Steffes; Josef Coresh
Journal:  Clin Chem       Date:  2014-09-08       Impact factor: 8.327

Review 9.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

10.  Comparative associations of diabetes risk factors with five measures of hyperglycemia.

Authors:  Anna K Poon; Stephen P Juraschek; Christie M Ballantyne; Michael W Steffes; Elizabeth Selvin
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.